Nanobles Corporation began as a quiet IP holding company and is now emerging as a leader in registered trademarks and innovation focused on the ECS, our Master Regulator. Once merged with the Global Cannabinoid Research Center, Nanobles now stands independently, holding a portfolio of nutraceutical, food, beverage, and pharmaceutical brands designed to support human balance in new ways - without cannabis or hemp.
Our nutraceutical flagship is Get Balanced®, paired with the Get Balanced® Research Initiative, which educates consumers on how lifestyle, diet, and plant-derived actives influence the ECS. Nano Terps® delivers functional essential-oil formulations, JANE® brings innovation to functional beverages, and Plant Chat® offers an AI-driven platform where users track health, log plant use, verify identity, and participate in survey studies that create valuable data for clinics and educators.
The Global Cannabinoid Research Center remains a separate entity, focused on cannabinoid science, ECS Balance Control, and how minor cannabinoids and endogenous molecules influence health. GCRC advances the science while Nanobles drives trademarks, licensing, and brand expansion.
I’m Mike Robinson, the Researcher OG, founder of GCRC and CEO of Nanobles Corp. I serve as a consultant and Cannabis Guide, helping patients and professionals understand plant medicine from Cannabis to Carrots. With more than a decade in research and over 15 registered trademarks, I specialize in practical ECS solutions and strategic partnerships.
My mission is to build collaborations that help people restore balance through the ECS, our Master Regulator. The system was discovered over 30 years ago, yet remains widely overlooked. It is time for medicine to catch up.
ResearcherOG.com
Nanobles.com
I’m Mike Robinson, founder of the Global Cannabinoid Research Center in Santa Barbara and CEO of Nanobles Corp. My path started with survival - as a multiple cancer survivor living with severe epilepsy, chronic Lyme, PTSD, and pain, I turned to cannabis oils and CBD when conventional medicine failed.
That journey took me from patient to researcher, speaker, and educator. I served as Director of Communications at the American Academy of Cannabinoid Medicine, became a published researcher and journalist, and taught clinicians worldwide about cannabinoid medicine. Along the way, I adopted my two daughters, Genevieve and Sydney, from the cannabis compassion program I ran. Our family’s story is part of the foundation behind everything I do.
